logo
SANS PRĖCĖDENT - TWO LEGENDS EXPLORE ONE OF THE WORLD'S MOST RESPECTED VARIETALS

SANS PRĖCĖDENT - TWO LEGENDS EXPLORE ONE OF THE WORLD'S MOST RESPECTED VARIETALS

ADELAIDE, Australia, Feb. 9, 2025 /PRNewswire/ -- Introducing Grange La Chapelle 2021, the result of curiosity and exploration that united cultures across two hemispheres. A blend that truly intertwines the rich heritage of French wine tradition and the innovative spirit of Australian craft.
A long-standing friendship between Caroline Frey, Chief Winemaker and vigneron, La Chapelle and Peter Gago, Chief Winemaker Penfolds Grange enabled this unexpected union to showcase what this varietal can achieve aromatically and structurally - coalescing different geographies, different soils and different winemaking cultures. Caroline and Peter both acknowledge that after many conversations, the time was right to work together.
This partnership created a pure varietal expression of equal parts in harmony. 50% La Chapelle France, from the steep, sun drenched slopes of the Hill of Hermitage and 50% Grange made from a collection of select South Australian vineyards: Barossa Valley, McLaren Vale, Clare Valley - including many old 19th-Century vines from a State that has never been scourged by phylloxera. It combines the attributes of French Syrah and Australian Shiraz, expressions that share a common ancestry yet have evolved into distinctive styles from their respective terroirs. A new wine different and yet respectful of parentage and original DNA - bravely using the flagship wine of both … not without risk.
Grange La Chapelle has its own identity. It is bold, yet elegant, structured yet expressive, offering a unique experience showcasing two legends. Caroline Frey said, 'As the project progressed, I saw the elegance in Grange and the strength in La Chapelle.'
This blend offers a true taste of the shared history of Syrah and Shiraz and future possibilities. While this is the first inaugural vintage release (2021), this wine is intended for future release, mother nature permitting - annually.
Peter Gago said, 'When things are real, all quickly becomes self-evident … This friendship created an idea, this idea became a trial, the trial became a wine. Who would have thought …" Peter goes on to reference earlier links, including a major La Chapelle and Grange tasting organised by The Institute of Masters of Wine many years back. More recently in 1987, a Hermitage Luncheon at Rakel Restaurant in New York (with a young chef, Thomas Keller!) co-hosted by Gerard Jaboulet and Max Schubert. Pouring the 1971 Penfolds Grange and 1978 Jaboulet Hermitage La Chapelle – certainly a celebration of Syrah and Shiraz. Fast-forward 38 years to 2025 and this connection has now come full-circle.
Eighteen customers from around the world were personally invited by both teams sensitively to hand sell Grange La Chapelle 2021 to their private customers. The wine is rare, and the make size small. A small allocation will be sold by Penfolds direct to consumer channel in Australia, and the USA.
Grange La Chapelle 2021 was celebrated at the inaugural global launch in Paris on February 9, 2025, at an intimate invite only Black-Tie evening hosted by Caroline Frey and Peter Gago, at Monnaie de Paris.
750ml RRP Australia AUD: $3,500 | 750ml RRP France €2,600. Visit grangexlachapelle.com for further information.
NOTES TO EDITOR:
About Grange La Chapelle:
Bold and unique. Uniting winemaking cultures, spanning hemispheres and time. Fate. A longstanding friendship between two winemakers created an idea. The idea became a trial. The trial became a wine. And then there were three – 2021 (bottled), 2022 (bottled) and 2023 (in barrel). Who would have thought? Syrah from the legendary Hill of Hermitage, La Chapelle, coupled with Shiraz from esteemed South Australian vineyards, Grange. The blend's raison d'être: One variety - reunited, reinterpreted, reassembled. La Chapelle named after the chapel on the top of the mound of granite on the left bank of Rhône, is a revered wine in Tain l'Hermitage, France. This Syrah from the revered Hermitage appellation is both powerful & mythical, made to last. Today La Chapelle vintages 1978, 1990, 1991 & 2015 vintages are much sought after globally, and the 1961 remains a 20th-Century wine legend.
Grange is named after the cottage at Magill Estate Winery South Australia (originally established by early settlers Dr Penfold and his wife Mary in 1844). Created in 1951, Grange has enjoyed a consecutive annual release for more than 70 years, and is also highly respected and endorsed by wine cognoscenti around the world. Prized vintages to relish today include 1952, 1962, 2008, 2010 & 2018
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Defibrillator Market worth US$16.44 billion by 2030 with 6.5% CAGR
Defibrillator Market worth US$16.44 billion by 2030 with 6.5% CAGR

Yahoo

timean hour ago

  • Yahoo

Defibrillator Market worth US$16.44 billion by 2030 with 6.5% CAGR

DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The global Defibrillator Market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. The growth in the defibrillator market is attributed to the increase in the prevalence of cardiovascular diseases, the increasing adult population with higher susceptibility to cardiac arrest, a strong focus of government organizations to enhance the accessibility of defibrillators by boosting the installation of public access defibrillators and providing training & programs on defibrillators. Additionally, the rapid expansion of healthcare infrastructure in emerging countries and strategic collaborations & partnerships among manufacturers to boost the new developments in defibrillators are likely to support the market's growth in the near future. Download PDF Brochure: Browse in-depth TOC on "Defibrillator Market" 337 - Tables57 - Figures296 - Pages By product, the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The implantable cardioverter defibrillators (ICDs) segment is anticipated to capture the largest global defibrillator market share by product in 2024. Timely intervention using implantable defibrillators during cardiac emergencies is a key advantage offered by this programmed device. Moreover, growing approvals of technologically advanced implantable defibrillators and rising preference for subcutaneous ICDs are likely to support the growth of this segment during the forecast period. By end users, the defibrillators market is segmented into Hospitals & Clinics, Cardiac Centers, Pre-hospital Settings, Public-Access Markets, Home Care Settings, and Other End Users. The hospitals & clinics segment dominated the global defibrillators market in 2024. The significant rise in hospitalization for critical cardiac conditions, the growing number of ICD and CRT-D implant procedures performed in hospitals, and the rising prevalence of cardiac diseases among geriatric patients are the major factors boosting the demand for defibrillators among target end-user segments during the study period. By geography, the defibrillator market is segmented based on the region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the defibrillator market. This can be attributed to the rapid adoption of technologically advanced defibrillators, favorable reimbursement policy, and the strong presence of manufacturers with a strong focus on strengthening R&D through investments in new product development. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to the presence of a large target patient pool, government initiatives to modernize & expand healthcare infrastructure, and expansion of market players in the region. Request Sample Pages : Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea). MEDTRONIC: MEDTRONIC Due to its extensive product portfolio, Medtronic is the leading player in the global implantable defibrillator market. The company primarily focuses on developing innovative products to treat and manage heart failure and heart rhythm disorders. The company focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions to strengthen its current position and gain a larger share of the neurovascular devices market. The company received the CE Mark for its implantable defibrillator systems, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan for managing irregular heart rhythms. Moreover, the company is also focusing on expanding its R&D capabilities to fuel product development and commercialization across mature and emerging markets. Koninklijke Philips N.V. Koninklijke Philips N.V. is a key player in the global defibrillator market, driven by its widely adopted HeartStart AED series. The company has established a strong presence through user-friendly, reliable devices designed for both public and professional use. Philips continues to lead with innovations such as real-time guidance, fast shock delivery, and connected care capabilities. Its strategic focus on accessibility, digital integration, and global deployment has reinforced its role in advancing out-of-hospital cardiac care. Boston Scientific Corporation Boston Scientific Corporation focuses on innovation and product launches in cardiac rhythm management to provide advanced solutions to healthcare professionals to improve the quality of life. The company continuously invests in R&D to launch new & innovative products. Boston Scientific primarily pursues the strategy of new product launches to sustain its position in the global defibrillators market. Regulatory approvals for its MRI-compatible defibrillators and technological advancements are expected to help the company maintain its position in the market. For more information, Inquire Now! Related Reports: Refurbished Medical Equipment Market IoT Medical Devices Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Defibrillator Companies and Defibrillator Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets

BreachLock Secures Global CREST Accreditation for Penetration Testing, Expanding Access to Trusted Security Testing Worldwide
BreachLock Secures Global CREST Accreditation for Penetration Testing, Expanding Access to Trusted Security Testing Worldwide

Yahoo

timean hour ago

  • Yahoo

BreachLock Secures Global CREST Accreditation for Penetration Testing, Expanding Access to Trusted Security Testing Worldwide

NEW YORK, Aug. 13, 2025 /PRNewswire/ -- BreachLock, a global leader in offensive security, announced today it has elevated its CREST membership and accreditation from regional to global status, underscoring its commitment to delivering world-class penetration testing services across the globe. CREST, the Council of Registered Ethical Security Testers, is an internationally recognized accreditation body that upholds the highest standards in the cybersecurity industry. CREST assesses penetration testing service providers' service-related policies, processes, and procedures through rigorous technical assessments and demanding audits, binding all accredited members to its strict code of conduct. Achieving global CREST accreditation marks a major milestone for BreachLock, showcasing its proven track record, expanding international reach, and unwavering commitment to delivering quality and consistency in penetration testing services worldwide. "This achievement is more than just a badge. It affirms to our global client base that BreachLock delivers the same level of quality, precision, and consistency no matter where in the world they operate," expressed Seemant Sehgal, Founder & CEO of BreachLock. "As threats grow more sophisticated with agentic offensive security, we deliver scalable, accredited testing anywhere our clients operate — maintaining the high standards that have earned their trust for seven years. We are the only vendor that covers both external professional services and offensive security platforms for internal pen testing teams." BreachLock continues to lead the evolution of penetration testing by delivering Penetration Testing as a Service (PTaaS) at scale through its Unified Platform, which pairs next-generation security testing automation with CREST-accredited human expertise to maximize its scalability, flexibility, and speed. This approach supports continuous and on-demand testing across diverse environments, including applications, APIs, internal and external networks, cloud infrastructures, IoT devices, and even large language models (LLMs). By combining automated testing with expert validation, BreachLock helps organizations identify, prioritize, and remediate risks faster, regardless of where their assets reside. Elevation to Global accreditation further underscores the company's ability to consistently deliver this standard of service worldwide. Learn more about BreachLock's CREST-accredited penetration testing services today at About BreachLockBreachLock is a global leader in offensive security, delivering scalable and continuous security testing. Trusted by global enterprises, BreachLock provides human-led and AI-powered Attack Surface Management, Penetration Testing as a Service (PTaaS), Red Teaming, and Adversarial Exposure Validation (AEV) solutions that help security teams stay ahead of adversaries. With a mission to make proactive security the new standard, BreachLock is shaping the future of cybersecurity through automation, data-driven intelligence, and expert-driven execution. Know Your Risk. Contact BreachLock today! Media Contact Megan Charrois Senior Marketing Executive megan.c@ View original content to download multimedia: SOURCE BreachLock Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

InventHelp Inventor Develops New Camera-Based Item Location Solution & App (LBT-7000)
InventHelp Inventor Develops New Camera-Based Item Location Solution & App (LBT-7000)

Yahoo

timean hour ago

  • Yahoo

InventHelp Inventor Develops New Camera-Based Item Location Solution & App (LBT-7000)

PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- "I thought there should be a mobile software application to create a real-time and location-based personal item finding solution," said an inventor, from Benton, Ark., "so I invented the SMART FINDER. My design eliminates the need to use multiple wireless locator devices." The invention provides a mobile app to optimize image recognition and visual location searches with digital cameras. In doing so, it offers an alternative to wireless tag location devices. As a result, it increases efficiency. It also could be used with specific digital camera devices or existing premises and vehicle camera surveillance systems. The invention features an adaptable and accurate design that is easy to use so it is ideal for households. The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-LBT-7000, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store